Demographics for patients randomized to 5.0 g/day SRT501 and placebo
| SRT501 (N = 6) | Placebo (N = 3) | |
|---|---|---|
| Age, y | 68.5 ± 10.8 | 64.3 ± 6.35 |
| Gender | ||
| Male | 5 | 1 |
| Female | 1 | 2 |
| Body mass index | 28.10 ± 4.35 | 26.87 ± 1.61 |
| Race, Caucasian | 100% | 100% |
| Days on study | 13.3 ± 1.03 | 14.0 ± 0.00 |
| Cumulative dose per subject, g | 66.7 ± 5.16 | 70.0 ± 0.00 |